Mark Ginski

Title: Mark Ginski: Innovator in Antitussive Compositions

Introduction

Mark Ginski is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of antitussive formulations. His innovative work has led to the creation of a patent that addresses important medical needs.

Latest Patents

Mark Ginski holds a patent for "Antitussive compositions comprising memantine." This patent describes compositions that include memantine along with various enhancers to improve absorption and elimination. The innovative approach taken in this patent aims to enhance the effectiveness of memantine in treating cough-related conditions.

Career Highlights

Ginski is associated with Cerecor, Inc., a company focused on developing innovative therapies for central nervous system disorders. His work at Cerecor has allowed him to explore new avenues in pharmaceutical research and development. With a total of 1 patent to his name, Ginski has established himself as a valuable contributor to the field.

Collaborations

Throughout his career, Mark Ginski has collaborated with talented individuals such as Blake Paterson and Brendan Canning. These collaborations have fostered a creative environment that encourages innovation and the development of new therapeutic solutions.

Conclusion

Mark Ginski's contributions to the field of antitussive compositions highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in pharmaceutical research and development.